A series of 4-methylsulfanylpyrimidin-2(1H)-one peptide nucleic acid analogs were synthesized and tested for their antiviral activity against hepatitis B virus. Plaque reduction infectivity assay was used to determine the virus count reduction as a result of treatment with tested compounds.Keywords: peptide nucleic acid analogs, pyrimidine nucleobases, anti-hepatitis B virus activity.Synthetic compounds that specifically recognize and bind to a specific DNA or RNA sequence of interest are potentially useful as antisense and antigene drugs or molecular probes, which have numerous applications in the field of molecular and experimental medicine [1][2][3]. Particularly successful DNA binding agents are found in a recently developed class of DNA analogs, the peptide nucleic acids (PNA) [4][5][6][7][8][9]. PNA are oligonucleotide analogs, in which the phosphodiester pentose backbone of DNA or RNA is replaced by a polyamide or peptide backbone [10]. For example, the phosphoribose backbone of natural oligonucleotide has been replaced by N-(2-aminoethyl)glycine whereby the purine/pirimidine base pair is attached to the glycine nitrogen through a methylene carbonyl linker [11]. The complete replacement of the ribose phosphate backbone with an artificial pseudopeptide backbone results in a remarkably improved binding to complementary nucleic acid sequences occurring with both high affinity and selectivity [12][13][14][15][16][17][18][19]. The hybridization properties of PNA have attracted widespread interest in this class of compounds [20][21][22]. Several reviews have covered the literature concerning new chemically modified PNA [23]. Their biological and chemical stability and their superior hybridization properties relative to natural oligonucleotides make them attracttive as potential therapeutic and biomolecular tools. Owing to the described significance of PNA and in connection with our work on the synthesis of new α-amino acid derivatives [24-28] and investigating their antiviral potential [29], we report here the synthesis and anti-hepatitis B virus (HBV) activity of new PNA with 4-methylsulfanylpyrimidin-2(1H)-one as the heterocyclic nucleobase.The coupling reaction at one of the nitrogen atoms of the heterocyclic base is the most effective method for introducing certain substituents with desired functionalities attached to the heterocycle. Thus, reaction of 4-(methylsulfanyl)uracils 1a-c [30] with ethyl chloroacetate in the presence of potassium carbonate afforded the corresponding nucleobase-substituted acetates 2a-c in 71-75% yields. The 1 H NMR spectra of compounds 2a-c showed the characteristic signals of the ester ethyl group and a singlet peak for the remaining CH 2 group at